Keith Michael Gottesdiener, CEO and President at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 3,934 shares at $30.00 ($118K) on 2019-02-13, disclosed to the SEC on 2019-02-15.
Open-market sale of $118k RYTM by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RYTM | SELL | 2019-02-28 | $128K | — | Filing → |
| RYTM | SELL | 2019-02-20 | $748K | — | Filing → |
| RYTM | SELL | 2019-01-24 | $945K | — | Filing → |